NCT02554344View on ClinicalTrials.gov

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DRUG

Curcumin

Patients will receive 500mg of curcumin administered orally, twice a day for 12 weeks.

Trial Locations (1)

75246

RECRUITING

Baylor Charles A. Sammons Cancer Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER